Lantern Pharma Ownership | Who Owns Lantern Pharma?

Overview RevenueFinancials Chart Transcripts

Lantern Pharma Ownership Summary

Lantern Pharma is owned by 12.41% institutional investors, 14.75% insiders, and 72.84% retail investors. Vanguard group is the largest institutional shareholder, holding 3.39% of LTRN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.37% of its assets in Lantern Pharma shares.

LTRN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Lantern Pharma	12.41%	14.75%	72.84%
Sector	Healthcare Stocks	88.01%	8.90%	3.09%
Industry	Biotech Stocks	109.70%	8.77%	-18.47%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	363.72K	3.39%	$1.70M
Newedge advisors	157.12K	1.46%	$733.79K
Geode capital management	86.35K	0.80%	$403.34K
Renaissance	81.80K	0.76%	$382.01K
Cm management	80.00K	0.74%	$373.60K
Blackrock	39.84K	0.37%	$186.06K
Redmond asset management	39.63K	0.37%	$185.09K
Two sigma investments, lp	34.78K	0.32%	$162.42K
Westside investment management	30.65K	0.28%	$97.78K
Horizon kinetics asset management	28.79K	0.27%	$134.45K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Cm management	80.00K	0.34%	$373.60K
Redmond asset management	39.63K	0.06%	$185.09K
Westside investment management	30.65K	0.02%	$97.78K
Newedge advisors	157.12K	0.01%	$733.79K
Sigma planning	28.40K	0.00%	$132.63K
Horizon kinetics asset management	28.79K	0.00%	$134.45K
Avantax planning partners	11.64K	0.00%	$54.36K
Perigon wealth management	14.60K	0.00%	$52.56K
Tocqueville asset management	17.00K	0.00%	$79.39K
Renaissance	81.80K	0.00%	$382.01K

Top Buyers

Holder	Shares	% Assets	Change
Two sigma investments, lp	34.78K	0.00%	34.78K
Blackrock	39.84K	-	20.18K
Renaissance	81.80K	0.00%	16.10K
Cm management	80.00K	0.34%	15.00K
Millennium management	10.13K	-	10.13K

Top Sellers

Holder	Shares	% Assets	Change
Susquehanna group, llp	-	-	-104.00K
Davenport	25.81K	0.00%	-28.00K
Pathway financial advisors	-	-	-25.00K
Jane street group	-	-	-24.87K
Meridian wealth management	-	-	-14.95K

New Positions

Holder	Shares	% Assets	Change	Value
Two sigma investments, lp	34.78K	0.00%	34.78K	$162.42K
Millennium management	10.13K	-	10.13K	$47.33K
Royal bank of canada	1.42K	-	1.42K	$7.00K

Sold Out

Holder	Change
Qube research	-2.00
Federated hermes	-74.00
Stone house investment management	-200.00
Cypress capital	-200.00
Pnc financial services group	-250.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	33	-19.51%	1,335,871	3.88%	12	8.66%	13	-27.78%	8	-42.86%
Jun 30, 2024	41	10.81%	1,286,036	16.02%	11	11.45%	18	-5.26%	14	40.00%
Mar 31, 2024	37	23.33%	1,108,429	1.09%	10	10.02%	19	137.50%	10	-16.67%
Dec 31, 2023	30	11.11%	1,096,470	-3.68%	10	9.19%	8	-	12	100.00%
Sep 30, 2023	27	3.85%	1,138,377	0.28%	10	9.59%	8	-33.33%	6	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	256.11K	2.37%	-
Vanguard Institutional Extnd Mkt Idx Tr	99.27K	0.92%	-
Fidelity Extended Market Index	45.80K	0.42%	-302.00
Horizon Kinetics Medical ETF	28.79K	0.27%	-
DFA US Targeted Value I	21.32K	0.20%	-
iShares Micro-Cap ETF	17.01K	0.16%	-
BlackRock Extended Equity Market K	15.56K	0.14%	-7.00
Fidelity Total Market Index	15.44K	0.14%	-
Extended Equity Market Fund K	15.35K	0.14%	-211.00
Fidelity Series Total Market Index	10.83K	0.10%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 24, 2024	Kreis Leslie W.	-	Sell	$87.91K
May 23, 2024	Kreis Leslie W.	-	Sell	$13.29K
May 24, 2024	Kreis Leslie W.	-	Sell	$26.92K
May 23, 2024	Kreis Leslie W.	-	Sell	$5.81K
May 23, 2024	Kreis Leslie W.	-	Sell	$43.40K

Insider Transactions Trends

Date	Buy	Sell
2024 Q3	-	-
2024 Q2	-	12
2024 Q1	-	24
2023 Q4	-	4
2022 Q4	-	10

LTRN Ownership FAQ

Who Owns Lantern Pharma?

Lantern Pharma shareholders are primarily institutional investors at 12.41%, followed by 14.75% insiders and 72.84% retail investors. The average institutional ownership in Lantern Pharma's industry, Biotech Stocks , is 109.70%, which Lantern Pharma falls below.

Who owns the most shares of Lantern Pharma?

Lantern Pharma’s largest shareholders are Vanguard group (363.72K shares, 3.39%), Newedge advisors (157.12K shares, 1.46%), and Geode capital management (86.35K shares, 0.80%). Together, they hold 5.65% of Lantern Pharma’s total shares outstanding.

Does Blackrock own Lantern Pharma?

Yes, BlackRock owns 0.37% of Lantern Pharma, totaling 39.84K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 186.06K$. In the last quarter, BlackRock increased its holdings by 20.18K shares, a 102.66% change.

Who is Lantern Pharma’s biggest shareholder by percentage of total assets invested?

Cm management is Lantern Pharma’s biggest shareholder by percentage of total assets invested, with 0.34% of its assets in 80K Lantern Pharma shares, valued at 373.6K$.

Who is the top mutual fund holder of Lantern Pharma shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Lantern Pharma shares, with 2.37% of its total shares outstanding invested in 256.11K Lantern Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools